Christos Coutifaris
Direttore/Membro del Consiglio presso American Society for Reproductive Medicine
Posizioni attive di Christos Coutifaris
Società | Posizione | Inizio | Fine |
---|---|---|---|
American Society for Reproductive Medicine
American Society for Reproductive Medicine Miscellaneous Commercial ServicesCommercial Services The American Society for Reproductive Medicine engages in multidisciplinary information, education, advocacy, and standards in the field of reproductive medicine. The non-profit company is based in Birmingham, AL. The CEO of the company is Richard Reindollar. | Direttore/Membro del Consiglio | - | - |
Storia della carriera di Christos Coutifaris
Precedenti posizioni note di Christos Coutifaris
Società | Posizione | Inizio | Fine |
---|---|---|---|
Nora Therapeutics, Inc.
Nora Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Nora Therapeutics, Inc. develops therapeutics to address clinical unmet needs in reproductive medicine. Its's lead product NT100, seeks to improve pregnancy outcomes in women undergoing in vitro fertilization or who have suffered recurrent spontaneous miscarriages. The company was founded by Darryl L. Carter and Chris B. McClain in 2007 and is headquartered in Palo Alto, CA. | Corporate Officer/Principal | - | - |
Statistiche
Distribuzione geografica
Stati Uniti | 3 |
Posizioni
Director/Board Member | 1 |
Corporate Officer/Principal | 1 |
Settori
Commercial Services | 2 |
Health Technology | 2 |
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Società collegate
Aziende private | 2 |
---|---|
American Society for Reproductive Medicine
American Society for Reproductive Medicine Miscellaneous Commercial ServicesCommercial Services The American Society for Reproductive Medicine engages in multidisciplinary information, education, advocacy, and standards in the field of reproductive medicine. The non-profit company is based in Birmingham, AL. The CEO of the company is Richard Reindollar. | Commercial Services |
Nora Therapeutics, Inc.
Nora Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Nora Therapeutics, Inc. develops therapeutics to address clinical unmet needs in reproductive medicine. Its's lead product NT100, seeks to improve pregnancy outcomes in women undergoing in vitro fertilization or who have suffered recurrent spontaneous miscarriages. The company was founded by Darryl L. Carter and Chris B. McClain in 2007 and is headquartered in Palo Alto, CA. | Health Technology |
- Borsa valori
- Insiders
- Christos Coutifaris
- Esperienza